Jill A Parnell1, Raylene A Reimer. 1. Department of Medical Sciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
Abstract
OBJECTIVE: To characterize the gastrointestinal tract at the onset and in well-established obesity. METHODS AND PROCEDURES: Lean (+/?) and obese (cp/cp) male JCR:LA-cp rats lacking a functional leptin receptor were killed at 3.5 weeks and 9 months of age and plasma concentrations of satiety hormones determined. The small intestine, colon, and stomach were measured, weighed, and mRNA levels of satiety genes quantified. RESULTS: At the onset of obesity, obese rats had greater intestine, colon, and liver mass when adjusted for body weight compared to lean rats. Conversely, adult rats with established obesity had lower intestine and colon mass and length after adjustment for body weight. Early changes in gene expression included decreased ghrelin mRNA levels in stomach and increased peptide YY (PYY) mRNA levels in duodenum of young obese rats. After massive accumulation of adipose tissue had occurred, adult obese rats had increased proglucagon and ghrelin mRNA expression in the proximal intestine. In the distal small intestine, obese rats had lower proglucagon, ghrelin, and PYY mRNA levels. Finally, at the onset and in well-established obesity, obese rats had higher plasma insulin, amylin, glucagon like peptide-1 (GLP-1), and PYY, a finding, with the exception of insulin, unique to this model. Plasma total ghrelin levels were significantly lower at the onset of obesity and established obesity compared to the lean rats. DISCUSSION: Several defects are manifested in the obese gut early on in the disease before the accumulation of large excesses of body fat and represent potential targets for early intervention in obesity.
OBJECTIVE: To characterize the gastrointestinal tract at the onset and in well-established obesity. METHODS AND PROCEDURES: Lean (+/?) and obese (cp/cp) male JCR:LA-cp rats lacking a functional leptin receptor were killed at 3.5 weeks and 9 months of age and plasma concentrations of satiety hormones determined. The small intestine, colon, and stomach were measured, weighed, and mRNA levels of satiety genes quantified. RESULTS: At the onset of obesity, obeserats had greater intestine, colon, and liver mass when adjusted for body weight compared to lean rats. Conversely, adult rats with established obesity had lower intestine and colon mass and length after adjustment for body weight. Early changes in gene expression included decreased ghrelin mRNA levels in stomach and increased peptide YY (PYY) mRNA levels in duodenum of young obeserats. After massive accumulation of adipose tissue had occurred, adult obeserats had increased proglucagon and ghrelin mRNA expression in the proximal intestine. In the distal small intestine, obeserats had lower proglucagon, ghrelin, and PYY mRNA levels. Finally, at the onset and in well-established obesity, obeserats had higher plasma insulin, amylin, glucagon like peptide-1 (GLP-1), and PYY, a finding, with the exception of insulin, unique to this model. Plasma total ghrelin levels were significantly lower at the onset of obesity and established obesity compared to the lean rats. DISCUSSION: Several defects are manifested in the obese gut early on in the disease before the accumulation of large excesses of body fat and represent potential targets for early intervention in obesity.
Authors: M Tschöp; T R Castañeda; H G Joost; C Thöne-Reineke; S Ortmann; S Klaus; M M Hagan; P C Chandler; K D Oswald; S C Benoit; R J Seeley; K P Kinzig; T H Moran; A G Beck-sickinger; N Koglin; R J Rodgers; J E Blundell; Y Ishii; A H Beattie; P Holch; D B Allison; K Raun; K Madsen; B S Wulff; C E Stidsen; M Birringer; O J Kreuzer; M Schindler; K Arndt; K Rudolf; M Mark; X Y Deng; D C Whitcomb; H Halem; J Taylor; J Dong; R Datta; M Culler; S Craney; D Flora; D Smiley; M L Heiman; D C Withcomb Journal: Nature Date: 2004-07-08 Impact factor: 49.962
Authors: Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom Journal: Nature Date: 2002-08-08 Impact factor: 49.962
Authors: D Dardevet; M C Moore; D Neal; C A DiCostanzo; W Snead; A D Cherrington Journal: Am J Physiol Endocrinol Metab Date: 2004-03-16 Impact factor: 4.310
Authors: Maartje C P Geraedts; Freddy J Troost; Marjet J M Munsters; Jos H C H Stegen; Rogier J de Ridder; Jose M Conchillo; Joanna W Kruimel; Ad A M Masclee; Wim H M Saris Journal: PLoS One Date: 2011-09-13 Impact factor: 3.240
Authors: Abdoulaye Diane; W David Pierce; Sandra E Kelly; Sharon Sokolik; Faye Borthwick; Miriam Jacome-Sosa; Rabban Mangat; Jesus Miguel Pradillo; Stuart McRae Allan; Megan R Ruth; Catherine J Field; Rebecca Hutcheson; Petra Rocic; James C Russell; Donna F Vine; Spencer D Proctor Journal: Front Nutr Date: 2016-10-10